This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Asia: Oligonucleotide & Peptide Therapeutics Scientific Forum


  • 00
  • 00
  • 00
  • 00
19-21 March 2024
Westin Miyako KyotoKyoto, Japan

Shonan iPark


Shonan Health Innovation Park (Shonan iPark) is Japan's first pharmaceutical-initiated science park, established in April 2018 when Takeda Pharmaceutical Company Limited (Takeda) opened its then in-house research center to outside organizations. It aims to become a place where industry, government, and academia from a wide range of industries and sizes can come together to accelerate health innovation. Shonan iPark is currently home to about 150 companies and more than 2,000 people (as of April, 2023) from not only pharmaceutical companies but also next-generation medicine, cell agriculture, AI, government, and other fields, forming an ecosystem.
The land and buildings are held in trust beneficiary rights by Industrial & Infrastructure Fund Investment Corporation (IIF), and the facilities and community are managed by iPark Institute Co., Ltd., which took over the business of Takeda.
The facility is managed by personnel with expertise in the life science business, and under the vision of "Bring innovative ideas to society", it aims to become a place where research can be accelerated and social implementation can be realized.